China Health Industries Holdings, Inc. (CHHE) Common Equity (2016 - 2024)
China Health Industries Holdings (CHHE) has disclosed Common Equity for 14 consecutive years, with -$2.4 million as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Common Equity fell 105.72% year-over-year to -$2.4 million, compared with a TTM value of -$2.4 million through Mar 2024, down 105.72%, and an annual FY2023 reading of $39.1 million, down 8.63% over the prior year.
- Common Equity was -$2.4 million for Q1 2024 at China Health Industries Holdings, down from -$2.3 million in the prior quarter.
- Across five years, Common Equity topped out at $44.8 million in Q3 2021 and bottomed at -$2.4 million in Q1 2024.
- Average Common Equity over 5 years is $37.0 million, with a median of $41.9 million recorded in 2020.
- The sharpest move saw Common Equity grew 15.1% in 2020, then crashed 105.72% in 2024.
- Year by year, Common Equity stood at $44.5 million in 2020, then increased by 0.61% to $44.8 million in 2021, then decreased by 6.12% to $42.0 million in 2022, then plummeted by 105.45% to -$2.3 million in 2023, then dropped by 4.71% to -$2.4 million in 2024.
- Business Quant data shows Common Equity for CHHE at -$2.4 million in Q1 2024, -$2.3 million in Q4 2023, and $38.7 million in Q3 2023.